Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hengxu Capital is a private equity fund of funds and direct investor supporting "advanced manufacturing, big healthcare, green mobility, and mobility ecosystems", part of the financial industrial investment platform of SAIC Motor, with over 37 billion yuan in assets under management as of 2023. It does not conduct R&D or clinical trials directly and instead invests in healthcare funds and companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hengxu Capital.